[Long-term therapy of retinal vasculopathies with oral administration of high doses of O-(beta-hydroxyethyl)-rutoside].
作者信息
Agolini G, Cavallini G M
出版信息
Clin Ter. 1987 Jan 31;120(2):101-10.
PMID:2972438
Abstract
摘要
相似文献
1
[Long-term therapy of retinal vasculopathies with oral administration of high doses of O-(beta-hydroxyethyl)-rutoside].
Clin Ter. 1987 Jan 31;120(2):101-10.
2
[Prevention of cystoid macular edema with O-beta-hydroxyethyl-rutoside (Venoruton) in a double-blind study].
Klin Monbl Augenheilkd. 1982 Jun;180(6):568-70. doi: 10.1055/s-2008-1055151.
3
[Vascular obturation in diabetic retinopathy using 0-beta-hydroxyethyl-rutoside].
Klin Monbl Augenheilkd. 1972 May;160(5):527-33.
4
5
Oral fluorescein angiography with the scanning laser ophthalmoscope in diabetic retinopathy: a case controlled comparison with intravenous fluorescein angiography.
Eye (Lond). 2005 Apr;19(4):411-7. doi: 10.1038/sj.eye.6701513.
6
Metabolism of hydroxyethylrutosides (HR): metabolism of [14C]-HR in man.
Arzneimittelforschung. 1976;26(5):925-8.
7
[Venoruton--used not only in venopathies? Symposium on O-(beta-hydroxyethyl)-rutoside (=Venoruton) in vascular diseases].
ZFA (Stuttgart). 1981 Sep 20;57(26):1758-60.
8
Diabetes as a risk factor for retinal neovascularization in retinal vein occlusion.
Ann Ophthalmol. 1989 Feb;21(2):65-6.
9
[Efficacy of troxerutin on the flow properties of blood under defined conditions of circulation. A double-blind study of patients with diabetic retinopathy and arteriosclerotic retinopathy].
Klin Monbl Augenheilkd. 1985 Jul;187(1):30-5. doi: 10.1055/s-2008-1050983.
10
Perivenular macular whitening during acute central retinal vein occlusion.
Arch Ophthalmol. 2003 Oct;121(10):1488-91. doi: 10.1001/archopht.121.10.1488.
引用本文的文献
1
Hydroxyethylrutosides. A review of its pharmacology, and therapeutic efficacy in venous insufficiency and related disorders.
Drugs. 1992 Dec;44(6):1013-32. doi: 10.2165/00003495-199244060-00009.
Zotero 插件